PT  - JOURNAL ARTICLE
AU  - Jacobson, Anne
ED  - Paganelli, Franck
TI  - Tailored Clopidogrel Dosing Reduces Adverse Events in Patients with Clopidogrel Resistance Undergoing PCI
DP  - 2009 Feb 01
TA  - MD Conference Express
PG  - 17--18
VI  - 8
IP  - 8
4099  - http://mdc.sagepub.com/content/8/8/17.short
4100  - http://mdc.sagepub.com/content/8/8/17.full
AB  - For patients who undergo nonemergent percutaneous coronary intervention (PCI), tailoring the loading dose of clopidogrel according to platelet reactivity reduced the rate of early stent thrombosis, according to findings from a new trial. Individualized dosing also reduced the incidence of major adverse cardiovascular events without increasing bleeding events.